Article thumbnail

A novel duplex real-time reverse transcriptase-polymerase chain reaction assay for the detection of hepatitis C viral RNA with armored RNA as internal control

By Shuang Meng and Jinming Li
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). AA: Strategic approach to produce low-cost, efficient, and stable competitive internal controls for detection of RNA viruses by use of reverse transcription-PCR.
  2. (2005). Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis
  3. (2009). Armored long RNA controls or standards for branched DNA assay for detection of human immunodeficiency virus type 1. J Clin Microbiol
  4. (2008). C: The development of a qualitative real-time RT-PCR assay for the detection of hepatitis C virus.
  5. (1996). Cartouzou G: Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.
  6. (2008). CG: An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach. Clin Chem Lab Med
  7. (2004). Claas EC: Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4.
  8. (1997). Diagnostic tests for hepatitis C. Hepatology
  9. (2004). Fach P: Practical considerations in design of internal amplification controls for diagnostic PCR assays.
  10. (2007). Frequency of very low HCV viremia detected by a highly sensitive HCVRNA assay.
  11. (2008). GC: Genetic variability in the 5' UTR and NS5A regions of hepatitis C virus RNA isolated from non-responding and responding patients with chronic HCV genotype 1 infection. Mem Inst Oswaldo Cruz
  12. (2004). Genetic diversity and evolution of hepatitis C virus--15 years on.
  13. (2009). Genetic variations in a well conserved 5'-untranslated region of hepatitis C virus genome isolated in Pakistan. J Virol Methods
  14. (2009). Goueli SA: Positional effect of mutations in 5'UTR of hepatitis C virus 4a on patients' response to therapy.
  15. (2005). Group: A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion
  16. (2002). Hepatitis C infection and the patient with end-stage renal disease. Hepatology
  17. (2000). Hepatitis C virus diagnosis and testing.
  18. (2002). Hoofnagle JH: National Institutes of Health Consensus Development Conference: Management of hepatitis C:
  19. (2001). Impraim C: Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
  20. (2008). JM: A novel real-time multiplex reverse transcriptase-polymerase chain reaction for the detection of HIV-1 RNA by using dual-specific armored RNA as internal control. Intervirology
  21. (1994). Lo KJ: Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody. Vox Sang
  22. (2002). Molecular diagnosis of viral hepatitis. Gastroenterology
  23. (2003). Niesters HG: Diagnosing herpesvirus infections by real-time amplification and rapid culture.
  24. (2007). Overestimation and underestimation of hepatitis C virus RNA levels in a widely used realtime polymerase chain reaction-based method. Hepatology
  25. (2009). Pawlotsky JM: Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification.
  26. (2009). Pawlotsky JM: The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples. Hepatology
  27. (2008). Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples. Diagn Microbiol Infect Dis
  28. (1992). RH: Sequence analysis of the 5' noncoding region of hepatitis C virus.
  29. (2008). Sarrazin C: Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
  30. (2000). Sridharan G: Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India.
  31. (2004). Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR.
  32. (2006). Tamalet C: Broad differences between the COBAS ampliprep total nucleic acid isolation-COBAS TaqMan 48 hepatitis C virus (HCV) and COBAS HCV monitor v2.0 assays for quantification of serum HCV RNA of non-1 genotypes.
  33. (2002). The burden of hepatitis C in the United States. Hepatology
  34. (1992). The declining risk of post-transfusion hepatitis C virus infection.
  35. (2010). WG: Sequence analysis of the 5' untranslated region in isolates of at least Received: 23
  36. (2006). Zeuzem S: Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J Clin Microbiol